{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:52:21Z","timestamp":1793371941426,"version":"4.5.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00210-025-04565-2","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:44:51Z","timestamp":1756367091000},"page":"1751-1768","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Melanoma and its fibroblastic allies: the emerging importance of CAFs in immune suppression, ECM modulation, and therapy resistance"],"prefix":"10.1007","volume":"399","author":[{"given":"Chou-Yi","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raed Obaid","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaafaru Sani","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Mansuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"M. M.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Kundlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Hussein","family":"Zwamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanen Mahmod","family":"Hulail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"4565_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41420-024-01910-x","volume":"10","author":"A Affinito","year":"2024","unstructured":"Affinito A, Quintavalle C, Chianese RV, Roscigno G, Fiore D, D\u2019Argenio V, Thomas G, Savarese A, Ingenito F, Cocca L (2024) MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p. Cell Death Discovery 10:140","journal-title":"Cell Death Discovery"},{"key":"4565_CR2","doi-asserted-by":"publisher","first-page":"7484","DOI":"10.3390\/ijms21207484","volume":"21","author":"Y-H Ahn","year":"2020","unstructured":"Ahn Y-H, Kim JS (2020) Long non-coding RNAs as regulators of interactions between cancer-associated fibroblasts and cancer cells in the tumor microenvironment. Int J Mol Sci 21:7484","journal-title":"Int J Mol Sci"},{"key":"4565_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-10-85","volume":"10","author":"PA Ascierto","year":"2012","unstructured":"Ascierto PA, Kirkwood JM, Grob J-J, Simeone E, Grimaldi AM, Maio M, Palmieri G, Testori A, Marincola FM, Mozzillo N (2012) The role of BRAF V600 mutation in melanoma. J Transl Med 10:1\u20139","journal-title":"J Transl Med"},{"key":"4565_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3389\/fimmu.2012.00283","volume":"3","author":"JL Astarita","year":"2012","unstructured":"Astarita JL, Acton SE, Turley SJ (2012) Podoplanin: emerging functions in development, the immune system, and cancer. Front Immunol 3:283","journal-title":"Front Immunol"},{"key":"4565_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217244","volume":"604","author":"D Athavale","year":"2024","unstructured":"Athavale D, Balch C, Zhang Y, Yao X, Song S (2024) The role of Hippo\/YAP1 in cancer-associated fibroblasts: literature review and future perspectives. Cancer Lett 604:217244","journal-title":"Cancer Lett"},{"key":"4565_CR6","doi-asserted-by":"crossref","unstructured":"Bai YP, Shang K, Chen H, Ding F, Wang Z, Liang C, Xu Y, Sun MH, LI YYJCs (2015) FGF\u20101\/\u20103\/FGFR 4 signaling in cancer\u2010associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP\u20107. 106: 1278\u20131287","DOI":"10.1111\/cas.12745"},{"key":"4565_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/PGP.0b013e31824d1891","volume":"31","author":"F Bartel","year":"2012","unstructured":"Bartel F, Balschun K, Gradhand E, Strauss HG, Dittmer J, Hauptmann S (2012) Inverse expression of cystein-rich 61 (Cyr61\/CCN1) and connective tissue growth factor (CTGF\/CCN2) in borderline tumors and carcinomas of the ovary. International Journal of Gynecological Pathology\u202f: Official Journal of the International Society of Gynecological Pathologists 31:405\u2013415","journal-title":"International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists"},{"key":"4565_CR8","doi-asserted-by":"crossref","unstructured":"Becker LM, O\u2019Connell JT, Vo AP, Cain MP, Tampe D, Bizarro L, Sugimoto H, McGow AK, Asara JM, Lovisa S (2020) Epigenetic reprogramming of cancer-associated fibroblasts deregulates glucose metabolism and facilitates progression of breast cancer. Cell reports 31","DOI":"10.1016\/j.celrep.2020.107701"},{"key":"4565_CR9","doi-asserted-by":"crossref","unstructured":"Benedicto A, Hernandez-Unzueta I, Sanz E, M\u00e1rquez J (2021) Ocoxin increases the antitumor effect of BRAF inhibition and reduces cancer associated fibroblast-mediated chemoresistance and protumoral activity in metastatic melanoma. Nutrients 13","DOI":"10.3390\/nu13020686"},{"key":"4565_CR10","doi-asserted-by":"crossref","unstructured":"Bhattacharjee S, Hamberger F, Ravichandra A, Miller M, Nair A, Affo S, Filliol A, Chin L, Savage TM, Yin D (2024a) Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. The Journal of clinical investigation 131","DOI":"10.1172\/JCI146987"},{"key":"4565_CR11","doi-asserted-by":"crossref","unstructured":"Bhattacharjee S, Hamberger F, Ravichandra A, Miller M, Nair A, Affo S, Filliol A, Chin L, Savage TM, Yin DJTJoci (2024b) Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. 131","DOI":"10.1172\/JCI146987"},{"key":"4565_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","volume":"9","author":"G Biffi","year":"2019","unstructured":"Biffi G, Oni TE, Spielman B, Hao Y, Elyada E, Park Y, Preall J, Tuveson DA (2019) IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov 9:282\u2013301","journal-title":"Cancer Discov"},{"key":"4565_CR13","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911466","volume":"12","author":"M Cangkrama","year":"2020","unstructured":"Cangkrama M, Wietecha M, Mathis N, Okumura R, Ferrarese L, Al-Nuaimi D, Antsiferova M, Dummer R, Innocenti M, Werner S (2020) A paracrine activin A-mDia2 axis promotes squamous carcinogenesis via fibroblast reprogramming. EMBO Mol Med 12:e11466","journal-title":"EMBO Mol Med"},{"key":"4565_CR14","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.3390\/cancers15164026","volume":"15","author":"G Castellani","year":"2023","unstructured":"Castellani G, Buccarelli M, Arasi MB, Rossi S, Pisanu ME, Bellenghi M, Lintas C, Tabolacci C (2023) BRAF mutations in melanoma: biological aspects, therapeutic implications, and circulating biomarkers. Cancers 15:4026","journal-title":"Cancers"},{"key":"4565_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3614","volume":"26","author":"X Cen","year":"2024","unstructured":"Cen X, Li M, Yao A, Zheng Y, Lai W (2024) Immune infiltration and clinical significance analyses of the cancer-associated fibroblast-related signature in skin cutaneous melanoma. J Gene Med 26:e3614","journal-title":"J Gene Med"},{"key":"4565_CR16","doi-asserted-by":"crossref","unstructured":"Chang AE, Karnell LH, Menck HRJCIIJotACS (1998) The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. 83: 1664\u20131678","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G"},{"key":"4565_CR17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41416-019-0566-7","volume":"121","author":"A Chatterjee","year":"2019","unstructured":"Chatterjee A, Jana S, Chatterjee S, Wastall LM, Mandal G, Nargis N, Roy H, Hughes TA, Bhattacharyya A (2019) MicroRNA-222 reprogrammed cancer-associated fibroblasts enhance growth and metastasis of breast cancer. Br J Cancer 121:679\u2013689","journal-title":"Br J Cancer"},{"key":"4565_CR18","doi-asserted-by":"publisher","first-page":"3098327","DOI":"10.1155\/2020\/3098327","volume":"2020","author":"Q Chen","year":"2020","unstructured":"Chen Q, Tan L, Jin Z, Liu Y, Zhang Z (2020) Downregulation of CRABP2 inhibit the tumorigenesis of hepatocellular carcinoma in vivo and in vitro. Biomed Res Int 2020:3098327","journal-title":"Biomed Res Int"},{"key":"4565_CR19","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.1038\/s41467-021-27563-3","volume":"12","author":"Y Chen","year":"2021","unstructured":"Chen Y, Yang S, Lovisa S, Ambrose CG, McAndrews KM, Sugimoto H, Kalluri R (2021) Type-I collagen produced by distinct fibroblast lineages reveals specific function during embryogenesis and Osteogenesis Imperfecta. Nat Commun 12:7199","journal-title":"Nat Commun"},{"key":"4565_CR20","doi-asserted-by":"crossref","unstructured":"Chen J, Zhang L, Zhu Y, Zhao D, Zhang J, Zhu Y, Pang J, Xiao Y, Wu Q, Wang YJST, Therapy T (2024) AKT2S128\/CCT\u03b1S315\/319\/323-positive cancer-associated fibroblasts (CAFs) mediate focal adhesion kinase (FAK) inhibitors resistance via secreting phosphatidylcholines (PCs). 9: 21","DOI":"10.1038\/s41392-023-01728-6"},{"key":"4565_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/jcb.25611","volume":"118","author":"RM DeRita","year":"2017","unstructured":"DeRita RM, Zerlanko B, Singh A, Lu H, Iozzo RV, Benovic JL, Languino LR (2017) c-Src, insulin-like growth factor I receptor, G-protein-coupled receptor kinases and focal adhesion kinase are enriched into prostate cancer cell exosomes. J Cell Biochem 118:66\u201373","journal-title":"J Cell Biochem"},{"key":"4565_CR22","doi-asserted-by":"crossref","unstructured":"Diab M, El-Rayes BFJJoCM, Treatment (2022) The heterogeneity of CAFs and immune cell populations in the tumor microenvironment of pancreatic adenocarcinoma. 8: N\/A-N\/A","DOI":"10.20517\/2394-4722.2022.60"},{"key":"4565_CR23","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1158\/1535-7163.MCT-16-0454","volume":"16","author":"L Ding","year":"2017","unstructured":"Ding L, Ren J, Zhang D, Li Y, Huang X, Ji J, Hu Q, Wang H, Ni Y, Hou Y (2017) The TLR3 agonist inhibit drug efflux and sequentially consolidates low-dose cisplatin-based chemoimmunotherapy while reducing side effects. Mol Cancer Ther 16:1068\u20131079","journal-title":"Mol Cancer Ther"},{"key":"4565_CR24","doi-asserted-by":"crossref","unstructured":"Fang X, Chen D, Yang X, Cao X, Cheng Q, Liu K, Xu P, Wang Y, Xu J, Zhao SJCDD (2024) Cancer associated fibroblasts-derived SULF1 promotes gastric cancer metastasis and CDDP resistance through the TGFBR3-mediated TGF-\u03b2 signaling pathway. 10: 111","DOI":"10.1038\/s41420-024-01882-y"},{"key":"4565_CR25","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.3390\/cells10113242","volume":"10","author":"M Farooq","year":"2021","unstructured":"Farooq M, Khan AW, Kim MS, Choi S (2021) The role of fibroblast growth factor (FGF) signaling in tissue repair and regeneration. Cells 10:3242","journal-title":"Cells"},{"key":"4565_CR26","doi-asserted-by":"crossref","unstructured":"Feng S, Ding B, Dai Z, Yin H, Ding Y, Liu S, Zhang K, Lin H, Xiao Z, Shen YJJoTM (2024) Cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter. 22: 280","DOI":"10.1186\/s12967-024-05085-y"},{"key":"4565_CR27","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41556-023-01208-7","volume":"25","author":"D Filipescu","year":"2023","unstructured":"Filipescu D, Carcamo S, Agarwal A, Tung N, Humblin \u00c9, Goldberg MS, Vyas NS, Beaumont KG, Demircioglu D, Sridhar S (2023) MacroH2A restricts inflammatory gene expression in melanoma cancer-associated fibroblasts by coordinating chromatin looping. Nat Cell Biol 25:1332\u20131345","journal-title":"Nat Cell Biol"},{"key":"4565_CR28","doi-asserted-by":"crossref","unstructured":"Fischer GM, Vashisht Gopal Y, McQuade JL, Peng W, DeBerardinis RJ, Davies MAJPc, research m (2018) Metabolic strategies of melanoma cells: mechanisms, interactions with the tumor microenvironment, and therapeutic implications. 31: 11\u201330","DOI":"10.1111\/pcmr.12661"},{"key":"4565_CR29","doi-asserted-by":"crossref","unstructured":"Forsberg EM, Lindberg MF, Jespersen H, Als\u00e9n S, Bagge RO, Donia M, Svane IM, Nilsson O, Ny L, Nilsson LMJCR (2019) HER2 CAR-T cells eradicate uveal melanoma and T-cell therapy\u2013resistant human melanoma in IL2 transgenic NOD\/SCID IL2 receptor knockout mice. 79: 899\u2013904","DOI":"10.1158\/0008-5472.CAN-18-3158"},{"key":"4565_CR30","doi-asserted-by":"publisher","first-page":"9678","DOI":"10.1038\/s41467-024-53908-9","volume":"15","author":"A Forsthuber","year":"2024","unstructured":"Forsthuber A, Aschenbrenner B, Korosec A, Jacob T, Annusver K, Krajic N, Kholodniuk D, Frech S, Zhu S, Purkhauser K (2024a) Cancer-associated fibroblast subtypes modulate the tumor-immune microenvironment and are associated with skin cancer malignancy. Nat Commun 15:9678","journal-title":"Nat Commun"},{"key":"4565_CR31","first-page":"9678","volume":"15","author":"A Forsthuber","year":"2024","unstructured":"Forsthuber A, Aschenbrenner B, Korosec A, Jacob T, Annusver K, Krajic N, Kholodniuk D, Frech S, Zhu S, Purkhauser KJNC (2024b) Cancer-Associated Fibroblast Subtypes Modulate the Tumor-Immune Microenvironment and are Associated with Skin Cancer Malignancy 15:9678","journal-title":"Cancer-Associated Fibroblast Subtypes Modulate the Tumor-Immune Microenvironment and are Associated with Skin Cancer Malignancy"},{"key":"4565_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.21873\/anticanres.16130","volume":"43","author":"N Fujii","year":"2023","unstructured":"Fujii N, Yashiro M, Hatano T, Fujikawa H, Motomura H (2023) CD9-positive exosomes derived from cancer-associated fibroblasts might inhibit the proliferation of malignant melanoma cells. Anticancer Res 43:25\u201333","journal-title":"Anticancer Res"},{"key":"4565_CR33","doi-asserted-by":"crossref","unstructured":"Gu J, Li X, Zhao L, Yang Y, Xue C, Gao Y, Li J, Han Q, Sun Z, Bai CJCd, disease (2021) The role of PKM2 nuclear translocation in the constant activation of the NF-\u03baB signaling pathway in cancer-associated fibroblasts. 12: 291","DOI":"10.1038\/s41419-021-03579-x"},{"issue":"2268\u20132279","key":"4565_CR34","volume":"140","author":"Y Guo","year":"2020","unstructured":"Guo Y, Zhang X, Zeng W, Zhang J, Cai L, Wu Z, Su J, Xiao Y, Liu N, Tang L (2020a) TRAF6 activates fibroblasts to cancer-associated fibroblasts through FGF19 in tumor microenvironment to benefit the malignant phenotype of melanoma cells. J Investig Dermatol 140(2268\u20132279):e2211","journal-title":"J Investig Dermatol"},{"key":"4565_CR35","doi-asserted-by":"crossref","unstructured":"Guo Y, Zhang X, Zeng W, Zhang J, Cai L, Wu Z, Su J, Xiao Y, Liu N, Tang LJJoID (2020b) TRAF6 activates fibroblasts to cancer-associated fibroblasts through FGF19 in tumor microenvironment to benefit the malignant phenotype of melanoma cells. 140: 2268\u20132279. e2211","DOI":"10.1016\/j.jid.2020.03.950"},{"key":"4565_CR36","doi-asserted-by":"crossref","unstructured":"Hajdara A, \u00c7ak\u0131r U, \u00c9rsek B, Sill\u00f3 P, Sz\u00e9ky B, Barna G, Faqi S, Gy\u00f6ngy M, K\u00e1rp\u00e1ti S, N\u00e9meth KJIJoMS (2023) Targeting melanoma-associated fibroblasts (MAFs) with activated \u03b3\u03b4 (V\u03b42) T cells: an in vitro cytotoxicity model. 24: 12893","DOI":"10.3390\/ijms241612893"},{"key":"4565_CR37","doi-asserted-by":"crossref","unstructured":"Higashino N, Koma YI, Hosono M, Takase N, Okamoto M, Kodaira H, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H (2019) Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma. Laboratory investigation; a journal of technical methods and pathology 99: 777\u2013792","DOI":"10.1038\/s41374-018-0185-6"},{"key":"4565_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12935-024-03220-9","volume":"24","author":"M-y Hsieh","year":"2024","unstructured":"Hsieh M-y, Hsu S-K, Liu T-Y, Wu C-Y, Chiu C-C (2024) Melanoma biology and treatment: a review of novel regulated cell death-based approaches. Cancer Cell Int 24:63","journal-title":"Cancer Cell Int"},{"key":"4565_CR39","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1080\/15384101.2019.1669380","volume":"18","author":"T Hu","year":"2019","unstructured":"Hu T, Hu J (2019) Melanoma-derived exosomes induce reprogramming fibroblasts into cancer-associated fibroblasts via Gm26809 delivery. Cell Cycle 18:3085\u20133094","journal-title":"Cell Cycle"},{"key":"4565_CR40","doi-asserted-by":"crossref","unstructured":"Huang J, Tsang W-Y, Li Z-H, Guan X-YJC, Gastroenterology M, Hepatology (2023) The origin, differentiation, and functions of cancer-associated fibroblasts in gastrointestinal cancer. 16: 503\u2013511","DOI":"10.1016\/j.jcmgh.2023.07.001"},{"key":"4565_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.653","volume":"5","author":"Y Huang","year":"2024","unstructured":"Huang Y, Wang X, Wen C, Wang J, Zhou H, Wu L (2024) Cancer-associated fibroblast-derived colony-stimulating factor 2 confers acquired osimertinib resistance in lung adenocarcinoma via promoting ribosome biosynthesis. MedComm 5:e653","journal-title":"MedComm"},{"key":"4565_CR42","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1158\/2767-9764.CRC-23-0571","volume":"4","author":"J Hutchenreuther","year":"2024","unstructured":"Hutchenreuther J, Nguyen J, Quesnel K, Vincent KM, Petitjean L, Bourgeois S, Boyd M, Bou-Gharios G, Postovit LM, Leask A (2024) Cancer-associated fibroblast-specific expression of the matricellular protein CCN1 coordinates neovascularization and stroma deposition in melanoma metastasis. Cancer Research Communications 4:556\u2013570","journal-title":"Cancer Research Communications"},{"key":"4565_CR43","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1111\/febs.17423","volume":"292","author":"M Iozzo","year":"2025","unstructured":"Iozzo M, Comito G, Ippolito L, Sandrini G, Pardella E, Pranzini E, Capone M, Madonna G, Ascierto PA, Chiarugi P (2025) Sex-related changes in lactate dehydrogenase A expression differently impact the immune response in melanoma. FEBS J 292:3056\u20133071","journal-title":"FEBS J"},{"key":"4565_CR44","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12967-020-02235-w","volume":"18","author":"NAN Jorge","year":"2020","unstructured":"Jorge NAN, Cruz JGV, Pretti MAM, Bonamino MH, Possik PA, Boroni M (2020) Poor clinical outcome in metastatic melanoma is associated with a microRNA-modulated immunosuppressive tumor microenvironment. J Transl Med 18:56","journal-title":"J Transl Med"},{"key":"4565_CR45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/jcmm.17126","volume":"26","author":"S Khashkhashi Moghadam","year":"2022","unstructured":"Khashkhashi Moghadam S, Bakhshinejad B, Khalafizadeh A, Mahmud Hussen B, Babashah S (2022) Non-coding RNA-associated competitive endogenous RNA regulatory networks: novel diagnostic and therapeutic opportunities for hepatocellular carcinoma. J Cell Mol Med 26:287\u2013305","journal-title":"J Cell Mol Med"},{"key":"4565_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030563","volume":"7","author":"S Kidd","year":"2012","unstructured":"Kidd S, Spaeth E, Watson K, Burks J, Lu H, Klopp A, Andreeff M, Marini FC (2012) Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS ONE 7:e30563","journal-title":"PLoS ONE"},{"key":"4565_CR47","doi-asserted-by":"crossref","unstructured":"Klemen ND, Wang M, Rubinstein JC, Olino K, Clune J, Ariyan S, Cha C, Weiss SA, Kluger HM, Sznol MJJfioc (2020) Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma. 8: e000341","DOI":"10.1136\/jitc-2019-000341"},{"key":"4565_CR48","doi-asserted-by":"crossref","unstructured":"Kotsiliti EJNRG, Hepatology (2022) Origin of CAFs in colorectal cancer. 19: 79\u201379","DOI":"10.1038\/s41575-021-00573-8"},{"key":"4565_CR49","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.3390\/ijms25063144","volume":"25","author":"PM Lai","year":"2024","unstructured":"Lai PM, Chan KM (2024) Roles of histone H2A variants in cancer development, prognosis, and treatment. Int J Mol Sci 25:3144","journal-title":"Int J Mol Sci"},{"key":"4565_CR50","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.3390\/cancers14133086","volume":"14","author":"E Lattmann","year":"2022","unstructured":"Lattmann E, Levesque MP (2022) The role of extracellular vesicles in melanoma progression. Cancers 14:3086","journal-title":"Cancers"},{"key":"4565_CR51","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.12659\/MSM.911862","volume":"25","author":"N Li","year":"2019","unstructured":"Li N, Liu Y, Pang H, Lee D, Zhou Y, Xiao Z (2019a) Methylation-mediated silencing of microRNA-211 decreases the sensitivity of melanoma cells to cisplatin. Medical Science Monitor\u202f: International Medical Journal of Experimental and Clinical Research 25:1590\u20131599","journal-title":"Medical Science Monitor : International Medical Journal of Experimental and Clinical Research"},{"key":"4565_CR52","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3390\/cells8060538","volume":"8","author":"Z Li","year":"2019","unstructured":"Li Z, Zhang J, Zhou J, Lu L, Wang H, Zhang G, Wan G, Cai S, Du J (2019b) Nodal facilitates differentiation of fibroblasts to cancer-associated fibroblasts that support tumor growth in melanoma and colorectal cancer. Cells 8:538","journal-title":"Cells"},{"key":"4565_CR53","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1038\/s41467-022-30306-7","volume":"13","author":"X Li","year":"2022","unstructured":"Li X, Yong T, Wei Z, Bie N, Zhang X, Zhan G, Li J, Qin J, Yu J, Zhang B, Gan L, Yang X (2022) Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts. Nat Commun 13:2794","journal-title":"Nat Commun"},{"key":"4565_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111836","volume":"131","author":"D Li","year":"2024","unstructured":"Li D, Huang P, Xia L, Leng W, Qin S (2024) Cancer-associated fibroblasts promote gastric cancer cell proliferation by paracrine FGF2-driven ribosome biogenesis. Int Immunopharmacol 131:111836","journal-title":"Int Immunopharmacol"},{"key":"4565_CR55","doi-asserted-by":"publisher","first-page":"7015","DOI":"10.2174\/0109298673282799231211113347","volume":"31","author":"W Lian","year":"2024","unstructured":"Lian W, Xiang P, Ye C, Xiong J (2024) Single-cell RNA sequencing analysis reveals the role of cancer-associated fibroblasts in skin melanoma. Curr Med Chem 31:7015\u20137029","journal-title":"Curr Med Chem"},{"key":"4565_CR56","doi-asserted-by":"crossref","unstructured":"Liu B, Pan S, Liu J, Kong CJG (2021) Cancer-associated fibroblasts and the related Runt-related transcription factor 2 (RUNX2) promote bladder cancer progression. 775: 145451","DOI":"10.1016\/j.gene.2021.145451"},{"key":"4565_CR57","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1158\/0008-5472.CAN-21-0614","volume":"82","author":"T Liu","year":"2022","unstructured":"Liu T, Zhou L, Xiao Y, Andl T, Zhang Y (2022) BRAF inhibitors reprogram cancer-associated fibroblasts to drive matrix remodeling and therapeutic escape in melanoma. Can Res 82:419\u2013432","journal-title":"Can Res"},{"key":"4565_CR58","doi-asserted-by":"crossref","unstructured":"Liu X, Li J, Yang X, Li X, Kong J, Qi D, Zhang F, Sun B, Liu Y, Liu TJIjoos (2023) Carcinoma-associated fibroblast-derived lysyl oxidase-rich extracellular vesicles mediate collagen crosslinking and promote epithelial-mesenchymal transition via p-FAK\/p-paxillin\/YAP signaling. 15: 32","DOI":"10.1038\/s41368-023-00236-1"},{"key":"4565_CR59","first-page":"3108","volume":"12","author":"K Louault","year":"2020","unstructured":"Louault K, Li R-R, DeClerck YA (2020) Cancer-Associated Fibroblasts: Understanding Their Heterogeneity Cancers 12:3108","journal-title":"Cancer-Associated Fibroblasts: Understanding Their Heterogeneity Cancers"},{"key":"4565_CR60","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jtos.2020.12.007","volume":"20","author":"B Ma","year":"2021","unstructured":"Ma B, Zhou Y, Liu R, Zhang K, Yang T, Hu C, Gao Y, Lan Q, Liu Y, Yang X (2021) Pigment epithelium-derived factor (PEDF) plays anti-inflammatory roles in the pathogenesis of dry eye disease. Ocul Surf 20:70\u201385","journal-title":"Ocul Surf"},{"key":"4565_CR61","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","volume":"40","author":"Z Ma","year":"2022","unstructured":"Ma Z, Li X, Mao Y, Wei C, Huang Z, Li G, Yin J, Liang X, Liu Z (2022) Interferon-dependent SLC14A1(+) cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer. Cancer Cell 40:1550-1565.e1557","journal-title":"Cancer Cell"},{"key":"4565_CR62","doi-asserted-by":"crossref","unstructured":"Mazurkiewicz J, Simiczyjew A, Dratkiewicz E, Pietraszek-Gremplewicz K, Majkowski M, Kot M, Zi\u0119tek M, Matkowski R, Nowak DJCC, Signaling (2022) Melanoma cells with diverse invasive potential differentially induce the activation of normal human fibroblasts. 20: 63","DOI":"10.1186\/s12964-022-00871-x"},{"key":"4565_CR63","doi-asserted-by":"crossref","unstructured":"Mazzeo L, Ghosh S, Di Cicco E, Isma J, Tavernari D, Samarkina A, Ostano P, Youssef MK, Simon C, Dotto GPJNc (2024) ANKRD1 is a mesenchymal-specific driver of cancer-associated fibroblast activation bridging androgen receptor loss to AP-1 activation. 15: 1038","DOI":"10.1038\/s41467-024-45308-w"},{"key":"4565_CR64","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/carcin\/bgy032","volume":"39","author":"GE Melling","year":"2018","unstructured":"Melling GE, Flannery SE, Abidin SA, Clemmens H, Prajapati P, Hinsley EE, Hunt S, Catto JWF, Coletta RD, Mellone M, Thomas GJ, Parkinson EK, Prime SS, Paterson IC, Buttle DJ, Lambert DW (2018) A miRNA-145\/TGF-\u03b21 negative feedback loop regulates the cancer-associated fibroblast phenotype. Carcinogenesis 39:798\u2013807","journal-title":"Carcinogenesis"},{"key":"4565_CR65","doi-asserted-by":"publisher","first-page":"114","DOI":"10.18632\/aging.101127","volume":"9","author":"M Mellone","year":"2016","unstructured":"Mellone M, Hanley CJ, Thirdborough S, Mellows T, Garcia E, Woo J, Tod J, Frampton S, Jenei V, Moutasim KA, Kabir TD, Brennan PA, Venturi G, Ford K, Herranz N, Lim KP, Clarke J, Lambert DW, Prime SS, Underwood TJ, Vijayanand P, Eliceiri KW, Woelk C, King EV, Gil J, Ottensmeier CH, Thomas GJ (2016) Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosis. Aging 9:114\u2013132","journal-title":"Aging"},{"key":"4565_CR66","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/sj.bjc.6605154","volume":"101","author":"X Meng","year":"2009","unstructured":"Meng X, Jin Y, Yu Y, Bai J, Liu G, Zhu J, Zhao Y, Wang Z, Chen F, Lee K (2009) Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Br J Cancer 101:327\u2013334","journal-title":"Br J Cancer"},{"key":"4565_CR67","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s42003-023-04571-1","volume":"6","author":"W Mohammed Ismail","year":"2023","unstructured":"Mohammed Ismail W, Mazzone A, Ghiraldini FG, Kaur J, Bains M, Munankarmy A, Bagwell MS, Safgren SL, Moore-Weiss J, Buciuc M (2023) MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming. Communications Biology 6:215","journal-title":"Communications Biology"},{"key":"4565_CR68","doi-asserted-by":"crossref","unstructured":"Morales D, Vigneron P, Ferreira I, Hamitou W, Magnano M, Mahenthiran L, Lok C, Vayssade M (2021) fibroblasts influence metastatic melanoma cell sensitivity to combined BRAF and MEK inhibition. Cancers 13","DOI":"10.3390\/cancers13194761"},{"key":"4565_CR69","doi-asserted-by":"crossref","unstructured":"Murgai M, Ju W, Eason M, Kline J, Beury DW, Kaczanowska S, Miettinen MM, Kruhlak M, Lei H, Shern JFJNm (2017) KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis. 23: 1176\u20131190","DOI":"10.1038\/nm.4400"},{"key":"4565_CR70","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1158\/0008-5472.CAN-15-2468","volume":"76","author":"NG Nwani","year":"2016","unstructured":"Nwani NG, Deguiz ML, Jimenez B, Vinokour E, Dubrovskyi O, Ugolkov A, Mazar AP, Volpert OV (2016) Melanoma cells block PEDF production in fibroblasts to induce the tumor-promoting phenotype of cancer-associated fibroblasts. Can Res 76:2265\u20132276","journal-title":"Can Res"},{"key":"4565_CR71","unstructured":"Pach E (2022) Functional role of fibroblast-derived MMP-14 in tumor growth and metastasis. Universit\u00e4t zu K\u00f6ln"},{"key":"4565_CR72","doi-asserted-by":"publisher","first-page":"20130516","DOI":"10.1098\/rstb.2013.0516","volume":"369","author":"D Pegtel","year":"2014","unstructured":"Pegtel D, Peferoen L, Amor S (2014) Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain. Philosophical Transactions of the Royal Society B: Biological Sciences 369:20130516","journal-title":"Philosophical Transactions of the Royal Society B: Biological Sciences"},{"key":"4565_CR73","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12943-023-01731-z","volume":"22","author":"L Pei","year":"2023","unstructured":"Pei L, Liu Y, Liu L, Gao S, Gao X, Feng Y, Sun Z, Zhang Y, Wang C (2023a) Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1\/PD-L1 immunotherapy for solid cancers. Mol Cancer 22:29","journal-title":"Mol Cancer"},{"key":"4565_CR74","doi-asserted-by":"crossref","unstructured":"Pei L, Liu Y, Liu L, Gao S, Gao X, Feng Y, Sun Z, Zhang Y, Wang CJMc (2023b) Roles of cancer-associated fibroblasts (CAFs) in anti-PD-1\/PD-L1 immunotherapy for solid cancers. 22: 29","DOI":"10.1186\/s12943-023-01731-z"},{"issue":"13","key":"4565_CR75","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1158\/0008-5472.CAN-12-3686","volume":"73","author":"E Penna","year":"2013","unstructured":"Penna E, Orso F, Cimino D, Vercellino I, Grassi E, Quaglino E, Turco E, Taverna D (2013) miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b Downmodulation Abstract. Cancer Res 73(13):4098\u20134111. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-3686","journal-title":"Cancer Res"},{"key":"4565_CR76","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12935-023-02862-5","volume":"23","author":"K Peng","year":"2023","unstructured":"Peng K, Zhang Y, Liu D, Chen J (2023) MMP2 is a immunotherapy related biomarker and correlated with cancer-associated fibroblasts infiltrate in melanoma. Cancer Cell Int 23:26","journal-title":"Cancer Cell Int"},{"key":"4565_CR77","unstructured":"Popovic A (2021) An investigation into the phenotypic switching of dermal fibroblasts into cancer-associated fibroblasts in the melanoma tumour microenvironment. Universit\u00e9 C\u00f4te d\u2019Azur; University of Cape Town"},{"key":"4565_CR78","doi-asserted-by":"crossref","unstructured":"Popovic A, Tartare-Deckert SJFiO (2022) Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance. 12: 924553","DOI":"10.3389\/fonc.2022.924553"},{"key":"4565_CR79","doi-asserted-by":"crossref","unstructured":"Pradhan R, Paul S, Das B, Sinha S, Dash SR, Mandal M, Kundu CNJTJoNB (2023) Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12\/IL-6-dependent pathway. 113: 109257","DOI":"10.1016\/j.jnutbio.2022.109257"},{"key":"4565_CR80","doi-asserted-by":"publisher","first-page":"9713","DOI":"10.1021\/acsnano.4c01499","volume":"18","author":"ZW Qiu","year":"2024","unstructured":"Qiu ZW, Zhong YT, Lu ZM, Yan N, Kong RJ, Huang JQ, Li ZF, Nie JM, Li R, Cheng H (2024) Breaking physical barrier of fibrotic breast cancer for photodynamic immunotherapy by remodeling tumor extracellular matrix and reprogramming cancer-associated fibroblasts. ACS Nano 18:9713\u20139735","journal-title":"ACS Nano"},{"key":"4565_CR81","first-page":"257","volume":"19","author":"M Quante","year":"2011","unstructured":"Quante M, Tu SP, Tomita H, Gonda T, Wang SS, Takashi S, Baik GH, Shibata W, DiPrete B (2011) Betz KSJCc. Bone Marrow-Derived Myofibroblasts Contribute to the Mesenchymal Stem Cell Niche and Promote Tumor Growth 19:257\u2013272","journal-title":"Bone Marrow-Derived Myofibroblasts Contribute to the Mesenchymal Stem Cell Niche and Promote Tumor Growth"},{"key":"4565_CR82","unstructured":"Quintanilla M, Carrasco-Ram\u00edrez P, Montero-Montero L, Ram\u00edrez-L\u00f3pez A, da Silva IL, Renart J, Mart\u00edn-Villar E (2016) Podoplanin promotes malignancy through a diversity of strategies. vascular 3: 1\u20137"},{"key":"4565_CR83","doi-asserted-by":"crossref","unstructured":"Romano V, Belviso I, Venuta A, Ruocco MR, Masone S, Aliotta F, Fiume G, Montagnani S, Avagliano A, Arcucci AJIJoMS (2021) Influence of tumor microenvironment and fibroblast population plasticity on melanoma growth, therapy resistance and immunoescape. 22: 5283","DOI":"10.3390\/ijms22105283"},{"key":"4565_CR84","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/path.4281","volume":"231","author":"P Sandoval","year":"2013","unstructured":"Sandoval P, Jim\u00e9nez-Heffernan JA, Rynne-Vidal \u00c1, P\u00e9rez-Lozano ML, Gilsanz \u00c1, Ruiz-Carpio V, Reyes R, Garc\u00eda-Bordas J, Stamatakis K, Dotor J, Majano PL, Fresno M, Caba\u00f1as C, L\u00f3pez-Cabrera M (2013) Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis. J Pathol 231:517\u2013531","journal-title":"J Pathol"},{"key":"4565_CR85","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.phrs.2016.07.017","volume":"111","author":"S Sandri","year":"2016","unstructured":"Sandri S, Fai\u00e3o-Flores F, Tiago M, Pennacchi PC, Massaro RR, Alves-Fernandes DK, Berardinelli GN, Evangelista AF, de Lima VV, Reis RM (2016) Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation. Pharmacol Res 111:523\u2013533","journal-title":"Pharmacol Res"},{"key":"4565_CR86","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1158\/1078-0432.CCR-15-0321","volume":"22","author":"A Santiago-Walker","year":"2016","unstructured":"Santiago-Walker A, Gagnon R, Mazumdar J, Casey M, Long GV, Schadendorf D, Flaherty K, Kefford R, Hauschild A, Hwu P (2016) Correlation of BRAF mutation status in circulating-free DNA and tumor and association with clinical outcome across four BRAFi and MEKi clinical trials. Clin Cancer Res 22:567\u2013574","journal-title":"Clin Cancer Res"},{"key":"4565_CR87","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1600-0625.2012.01510.x","volume":"21","author":"I Satzger","year":"2012","unstructured":"Satzger I, Mattern A, Kuettler U, Weinspach D, Niebuhr M, Kapp A, Gutzmer R (2012) microRNA-21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells. Exp Dermatol 21:509\u2013514","journal-title":"Exp Dermatol"},{"key":"4565_CR88","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1158\/2767-9764.CRC-22-0486","volume":"3","author":"PD Shah","year":"2023","unstructured":"Shah PD, Huang AC, Xu X, Orlowski R, Amaravadi RK, Schuchter LM, Zhang P, Tchou J, Matlawski T, Cervini A, Shea J, Gilmore J, Lledo L, Dengel K, Marshall A, Wherry EJ, Linette GP, Brennan A, Gonzalez V, Kulikovskaya I, Lacey SF, Plesa G, June CH, Vonderheide RH, Mitchell TC (2023) Phase I trial of autologous RNA-electroporated cMET-directed CAR T cells administered intravenously in patients with melanoma and breast carcinoma. Cancer Research Communications 3:821\u2013829","journal-title":"Cancer Research Communications"},{"key":"4565_CR89","first-page":"963","volume":"75","author":"Y Sharon","year":"2015","unstructured":"Sharon Y, Raz Y, Cohen N, Ben-Shmuel A, Schwartz H, Geiger T (2015) Erez NJCr. Tumor-Derived Osteopontin Reprograms Normal Mammary Fibroblasts to Promote Inflammation and Tumor Growth in Breast Cancer 75:963\u2013973","journal-title":"Tumor-Derived Osteopontin Reprograms Normal Mammary Fibroblasts to Promote Inflammation and Tumor Growth in Breast Cancer"},{"key":"4565_CR90","doi-asserted-by":"crossref","unstructured":"Shelton M, Anene C, Nsengimana J, Roberts W, Newton-Bishop J, Boyne J (2021a) The role of CAF derived exosomal microRNAs in the tumour microenvironment of melanoma. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1875: 188456","DOI":"10.1016\/j.bbcan.2020.188456"},{"key":"4565_CR91","doi-asserted-by":"crossref","unstructured":"Shelton M, Anene C, Nsengimana J, Roberts W, Newton-Bishop J, Boyne JJBeBA-RoC (2021b) The role of CAF derived exosomal microRNAs in the tumour microenvironment of melanoma. 1875: 188456","DOI":"10.1016\/j.bbcan.2020.188456"},{"key":"4565_CR92","doi-asserted-by":"crossref","unstructured":"Shi X, Young CD, Zhou H, Wang X-JJB (2020) Transforming growth factor-\u03b2 signaling in fibrotic diseases and cancer-associated fibroblasts. 10: 1666","DOI":"10.3390\/biom10121666"},{"key":"4565_CR93","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal AJCacjfc (2023) Cancer statistics, 2023. 73: 17\u201348","DOI":"10.3322\/caac.21763"},{"key":"4565_CR94","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fmolb.2015.00019","volume":"2","author":"D Singh","year":"2015","unstructured":"Singh D, Srivastava SK, Chaudhuri TK, Upadhyay G (2015) Multifaceted role of matrix metalloproteinases (MMPs). Front Mol Biosci 2:19","journal-title":"Front Mol Biosci"},{"key":"4565_CR95","doi-asserted-by":"crossref","unstructured":"Soltantoyeh T, Akbari B, Karimi A, Mahmoodi Chalbatani G, Ghahri-Saremi N, Hadjati J, Hamblin MR, Mirzaei HRJC (2021) Chimeric antigen receptor (CAR) T cell therapy for metastatic melanoma: challenges and road ahead. 10: 1450","DOI":"10.3390\/cells10061450"},{"key":"4565_CR96","first-page":"2175","volume":"16","author":"J Song","year":"2025","unstructured":"Song J, Wei R, Liu C, Zhao Z, Liu X, Wang Y, Liu F, Liu XJNC (2025) Antigen-Presenting Cancer Associated Fibroblasts Enhance Antitumor Immunity and Predict Immunotherapy Response 16:2175","journal-title":"Antigen-Presenting Cancer Associated Fibroblasts Enhance Antitumor Immunity and Predict Immunotherapy Response"},{"key":"4565_CR97","doi-asserted-by":"publisher","first-page":"64274","DOI":"10.18632\/oncotarget.11729","volume":"7","author":"C Sorrentino","year":"2016","unstructured":"Sorrentino C, Miele L, Porta A, Pinto A, Morello S (2016) Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression. Oncotarget 7:64274\u201364288","journal-title":"Oncotarget"},{"key":"4565_CR98","doi-asserted-by":"publisher","first-page":"53558","DOI":"10.18632\/oncotarget.10669","volume":"7","author":"X Sun","year":"2016","unstructured":"Sun X, Li J, Sun Y, Zhang Y, Dong L, Shen C, Yang L, Yang M, Li Y, Shen G (2016) miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR\/IGF-1R\/CRAF and inhibiting the MAPK and PI3K\/AKT signaling pathways. Oncotarget 7:53558","journal-title":"Oncotarget"},{"key":"4565_CR99","doi-asserted-by":"crossref","unstructured":"Taguchi A, Kawana K, Tomio K, Yamashita A, Isobe Y, Nagasaka K, Koga K, Inoue T, Nishida H, Kojima SJPo (2014) Matrix metalloproteinase (MMP)-9 in cancer-associated fibroblasts (CAFs) is suppressed by omega-3 polyunsaturated fatty acids in vitro and in vivo. 9: e89605","DOI":"10.1371\/journal.pone.0089605"},{"key":"4565_CR100","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.3390\/cancers13235944","volume":"13","author":"J Tang","year":"2021","unstructured":"Tang J, Fang X, Chen J, Zhang H, Tang Z (2021) Long non-coding RNA (lncRNA) in oral squamous cell carcinoma: biological function and clinical application. Cancers 13:5944","journal-title":"Cancers"},{"key":"4565_CR101","first-page":"215","volume":"64","author":"S Tauch","year":"2025","unstructured":"Tauch S, Kast B, Lohr S, Kemm L, Sator-Schmitt M, Gengenbacher N, Augustin HG, Angel PJMC (2025) CAF Specific Expression of Podoplanin May Be Dispensable for the Malignancy of Malignant Melanoma 64:215\u2013220","journal-title":"CAF Specific Expression of Podoplanin May Be Dispensable for the Malignancy of Malignant Melanoma"},{"key":"4565_CR102","doi-asserted-by":"crossref","unstructured":"Thongchot S, Jamjuntra P, Therasakvichya S, Warnnissorn M, Ferraresi A, Thuwajit P, Isidoro C, Thuwajit CJIJoO (2021) Interleukin\u20118 released by cancer\u2011associated fibroblasts attenuates the autophagy and promotes the migration of ovarian cancer cells. 58: 1\u201314","DOI":"10.3892\/ijo.2021.5194"},{"key":"4565_CR103","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.12659\/MSM.894826","volume":"21","author":"Y Tian","year":"2015","unstructured":"Tian Y, Wei W, Li L, Yang R (2015) Down-regulation of miR-148a promotes metastasis by DNA methylation and is associated with prognosis of skin cancer by targeting TGIF2. Medical Science Monitor\u202f: International Medical Journal of Experimental and Clinical Research 21:3798\u20133805","journal-title":"Medical Science Monitor : International Medical Journal of Experimental and Clinical Research"},{"key":"4565_CR104","first-page":"32","volume":"7","author":"S Tokhanbigli","year":"2024","unstructured":"Tokhanbigli S, Haghi M, Dua K, Oliver BGG (2024) Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer. Cancer Drug Resistance (Alhambra, Calif) 7:32","journal-title":"Cancer Drug Resistance (Alhambra, Calif)"},{"key":"4565_CR105","doi-asserted-by":"crossref","unstructured":"Tsoumakidou MJNRC (2023) The advent of immune stimulating CAFs in cancer. 23: 258\u2013269","DOI":"10.1038\/s41568-023-00549-7"},{"key":"4565_CR106","first-page":"230","volume":"24","author":"F Volat","year":"2025","unstructured":"Volat F, Medhi R, Maggs LZ, Deken MA, Price A, Andrews L, Clark J, Taylor D, Carruthers A (2025) Taylor-Smith EJMCT. Pancreatic CAF-Derived Autotaxin Drives Autocrine CTGF Expression to Modulate Protumorigenic Signaling 24:230\u2013241","journal-title":"Pancreatic CAF-Derived Autotaxin Drives Autocrine CTGF Expression to Modulate Protumorigenic Signaling"},{"key":"4565_CR107","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13046-018-0995-9","volume":"38","author":"R Wang","year":"2019","unstructured":"Wang R, Sun Y, Yu W, Yan Y, Qiao M, Jiang R, Guan W, Wang L (2019) Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT. Journal of Experimental & Clinical Cancer Research\u202f: CR 38:20","journal-title":"Journal of Experimental & Clinical Cancer Research : CR"},{"key":"4565_CR108","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s12079-022-00674-2","volume":"16","author":"Z Wang","year":"2022","unstructured":"Wang Z, An J, Zhu D, Chen H, Lin A, Kang J, Liu W, Kang X (2022) Periostin: an emerging activator of multiple signaling pathways. Journal of Cell Communication and Signaling 16:515\u2013530","journal-title":"Journal of Cell Communication and Signaling"},{"key":"4565_CR109","doi-asserted-by":"crossref","unstructured":"Wang X, Qu Y, Ji J, Liu H, Luo H, Li J, Han XJII (2024) Colorectal cancer cells establish metabolic reprogramming with cancer-associated fibroblasts (CAFs) through lactate shuttle to enhance invasion, migration, and angiogenesis. 143: 113470","DOI":"10.1016\/j.intimp.2024.113470"},{"key":"4565_CR110","doi-asserted-by":"crossref","unstructured":"Wang D, Li L, Zhang Y, Ye KJMB (2025) Lipopolysaccharide-educated cancer-associated fibroblasts facilitate malignant progression of ovarian cancer cells via the NF-kB\/IL-6\/JAK2 signal transduction. 67: 317\u2013328","DOI":"10.1007\/s12033-024-01055-3"},{"key":"4565_CR111","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/bs.acc.2015.12.005","volume":"74","author":"TL Whiteside","year":"2016","unstructured":"Whiteside TL (2016) Tumor-derived exosomes and their role in cancer progression. Adv Clin Chem 74:103\u2013141","journal-title":"Adv Clin Chem"},{"issue":"Suppl 1","key":"4565_CR112","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12307-009-0025-8","volume":"2","author":"IP Witz","year":"2009","unstructured":"Witz IP (2009) The tumor microenvironment: the making of a paradigm. Cancer Microenvironment\u202f: Official Journal of the International Cancer Microenvironment Society 2(Suppl 1):9\u201317","journal-title":"Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society"},{"key":"4565_CR113","doi-asserted-by":"crossref","unstructured":"Xiong Z, Zhuang RL, Yu SL, Xie ZX, Peng SR, Li ZA, Li BH, Xie JJ, Li YN, Li KW, Huang H (2024) Cancer-associated fibroblasts regulate mitochondrial metabolism and inhibit chemosensitivity via ANGPTL4-IQGAP1 axis in prostate cancer. Journal of advanced research","DOI":"10.1016\/j.jare.2024.12.003"},{"key":"4565_CR114","doi-asserted-by":"crossref","unstructured":"Xu J, Bian L, You D, Li Z, Wang T, Li Y, Ren X, He YJCCI (2024) PDGF-BB accelerates TSCC via fibroblast lactates limiting miR-26a-5p and boosting mitophagy. 24: 5","DOI":"10.1186\/s12935-023-03172-6"},{"key":"4565_CR115","doi-asserted-by":"crossref","unstructured":"Xue C, Gao Y, Li X, Zhang M, Yang Y, Han Q, Sun Z, Bai C, Zhao RCJSCR, Therapy (2022) Mesenchymal stem cells derived from adipose accelerate the progression of colon cancer by inducing a MT-CAFs phenotype via TRPC3\/NF-KB axis. 13: 335","DOI":"10.1186\/s13287-022-03017-5"},{"key":"4565_CR116","doi-asserted-by":"crossref","unstructured":"Yagi T, Kagawa S, Nogi S, Taniguchi A, Yoshimoto M, Suemori K, Nagai Y, Fujita S, Kuroda S, Kikuchi SJCI, Immunotherapy (2025) Cancer-associated fibroblasts promote pro-tumor functions of neutrophils in pancreatic cancer via IL-8: potential suppression by pirfenidone. 74: 1\u201311","DOI":"10.1007\/s00262-025-03946-z"},{"key":"4565_CR117","doi-asserted-by":"crossref","unstructured":"Yu Y, Xiao C, Tan L, Wang Q, Li X, Feng YJBjoc (2014) Cancer-associated fibroblasts induce epithelial\u2013mesenchymal transition of breast cancer cells through paracrine TGF-\u03b2 signalling. 110: 724\u2013732","DOI":"10.1038\/bjc.2013.768"},{"key":"4565_CR118","first-page":"141","volume":"43","author":"B Zarin","year":"2021","unstructured":"Zarin B, Rafiee L, Daneshpajouhnejad P, Haghjooy Javanmard SJTB (2021) A Review on the Role of CAFs and CAF-Derived Exosomes in Progression and Metastasis of Digestive System Cancers 43:141\u2013157","journal-title":"A Review on the Role of CAFs and CAF-Derived Exosomes in Progression and Metastasis of Digestive System Cancers"},{"key":"4565_CR119","first-page":"10123","volume":"67","author":"EM Zeisberg","year":"2007","unstructured":"Zeisberg EM, Potenta S, Xie L, Zeisberg M (2007) Kalluri RJCr. Discovery of Endothelial to Mesenchymal Transition as a Source for Carcinoma-Associated Fibroblasts 67:10123\u201310128","journal-title":"Discovery of Endothelial to Mesenchymal Transition as a Source for Carcinoma-Associated Fibroblasts"},{"key":"4565_CR120","doi-asserted-by":"publisher","first-page":"261","DOI":"10.32604\/or.2023.042345","volume":"32","author":"S Zeng","year":"2023","unstructured":"Zeng S, Chen XI, Yi Q, Thakur A, Yang H, Yan Y, Liu S (2023) CRABP2 regulates infiltration of cancer-associated fibroblasts and immune response in melanoma. Oncol Res 32:261\u2013272","journal-title":"Oncol Res"},{"key":"4565_CR121","doi-asserted-by":"crossref","unstructured":"Zhang D, Song Y, Li D, Liu X, Pan Y, Ding L, Shi G, Wang Y, Ni Y, Hou YJMo (2022) Cancer\u2010associated fibroblasts promote tumor progression by lncRNA\u2010mediated RUNX2\/GDF10 signaling in oral squamous cell carcinoma. 16: 780\u2013794","DOI":"10.1002\/1878-0261.12935"},{"key":"4565_CR122","doi-asserted-by":"crossref","unstructured":"Zhang H, Yue X, Chen Z, Liu C, Wu W, Zhang N, Liu Z, Yang L, Jiang Q, Cheng QJMC (2023) Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. 22: 159","DOI":"10.1186\/s12943-023-01860-5"},{"key":"4565_CR123","doi-asserted-by":"crossref","unstructured":"Zhang P, Wang Q, Lu W, Zhang F, Wu D, Sun JJSR (2024) NNT-AS1 in CAFs-derived exosomes promotes progression and glucose metabolism through miR-889\u20133p\/HIF-1\u03b1 in pancreatic adenocarcinoma. 14: 6979","DOI":"10.1038\/s41598-024-57769-6"},{"key":"4565_CR124","doi-asserted-by":"crossref","unstructured":"Zhou D, Zheng LJCmj (2024) Recent advances in cancer-associated fibroblast: Biomarkers, signaling pathways, and therapeutic opportunities. 137: 638\u2013650","DOI":"10.1097\/CM9.0000000000003031"},{"key":"4565_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-018-0911-3","volume":"37","author":"X Zhou","year":"2018","unstructured":"Zhou X, Yan T, Huang C, Xu Z, Wang L, Jiang E, Wang H, Chen Y, Liu K, Shao Z (2018a) Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1\/JAK2\/STAT3 signaling pathway. J Exp Clin Cancer Res 37:1\u201315","journal-title":"J Exp Clin Cancer Res"},{"key":"4565_CR126","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s13046-018-0911-3","volume":"37","author":"X Zhou","year":"2018","unstructured":"Zhou X, Yan T, Huang C, Xu Z, Wang L, Jiang E, Wang H, Chen Y, Liu K, Shao Z, Shang Z (2018b) Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1\/JAK2\/STAT3 signaling pathway. Journal of Experimental & Clinical Cancer Research\u202f: CR 37:242","journal-title":"Journal of Experimental & Clinical Cancer Research : CR"},{"key":"4565_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116831","volume":"235","author":"G Zhu","year":"2019","unstructured":"Zhu G, Cheng Z, Huang Y, Zheng W, Yang S, Lin C, Ye J (2019) TRAF6 promotes the progression and growth of colorectal cancer through nuclear shuttle regulation NF-kB\/c-jun signaling pathway. Life Sci 235:116831","journal-title":"Life Sci"},{"key":"4565_CR128","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.7150\/thno.89805","volume":"14","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Fang S, Fan B, Xu K, Xu L, Wang L, Zhu L, Chen C, Wu R, Ni J (2024) Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer. Theranostics 14:1683","journal-title":"Theranostics"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04565-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04565-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04565-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T02:03:52Z","timestamp":1771553032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04565-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":128,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4565"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04565-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}